These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
522 related articles for article (PubMed ID: 32972314)
1. Antiplatelet Therapy for Transient Ischemic Attack and Minor Stroke. Xiong Y; Bath PM Stroke; 2020 Nov; 51(11):3472-3474. PubMed ID: 32972314 [No Abstract] [Full Text] [Related]
2. Antiplatelet therapy for transient ischaemic attack and minor ischaemic stroke. Kalladka D; Rounis E Br J Hosp Med (Lond); 2020 Jun; 81(6):1-3. PubMed ID: 32589536 [TBL] [Abstract][Full Text] [Related]
3. Comparison of Ticagrelor vs Clopidogrel in Addition to Aspirin in Patients With Minor Ischemic Stroke and Transient Ischemic Attack: A Network Meta-analysis. Lun R; Dhaliwal S; Zitikyte G; Roy DC; Hutton B; Dowlatshahi D JAMA Neurol; 2022 Feb; 79(2):141-148. PubMed ID: 34870698 [TBL] [Abstract][Full Text] [Related]
4. Meta-Analysis of Usefulness of Antiplatelet Therapy in Ischemic Stroke or Transient Ischemic Attack. Medranda GA; Zhang C; Doros G; Yerasi C; Case BC; Weintraub WS; Waksman R Am J Cardiol; 2021 Aug; 153():129-134. PubMed ID: 34226040 [TBL] [Abstract][Full Text] [Related]
5. Ticagrelor vs Clopidogrel in addition to Aspirin in minor ischemic stroke/ transient ischemic attack-Protocol for a systematic review and network meta-analysis. Zitikyte G; Roy DC; Dhaliwal S; Lun R; Hutton B; Shorr R; Dowlatshahi D PLoS One; 2021; 16(4):e0250553. PubMed ID: 33909676 [TBL] [Abstract][Full Text] [Related]
6. Ticagrelor plus aspirin in patients with minor ischemic stroke and transient ischemic attack: a network meta-analysis. Li M; Yang Q; Shi J; Zhang X; Lin H; Ge F BMC Neurol; 2023 Aug; 23(1):303. PubMed ID: 37580668 [TBL] [Abstract][Full Text] [Related]
7. New opportunities to optimize antithrombotic therapy for secondary stroke prevention. Kim AS; Easton JD Int J Stroke; 2019 Apr; 14(3):220-222. PubMed ID: 30722755 [TBL] [Abstract][Full Text] [Related]
8. Empiric treatment with aspirin and ticagrelor is the most cost-effective strategy in patients with minor stroke or transient ischemic attack. Narasimhalu K; Chan J; Ang YK; De Silva DA; Tan KB Int J Stroke; 2024 Feb; 19(2):209-216. PubMed ID: 37679898 [TBL] [Abstract][Full Text] [Related]
9. Dual Antiplatelet Therapy for Minor Stroke and High-Risk Transient Ischemic Attack. Liu L; Dowlatshahi D Stroke; 2018 Sep; 49(9):2278-2279. PubMed ID: 30355000 [No Abstract] [Full Text] [Related]
10. Update on Dual Antiplatelet Therapy for Secondary Stroke Prevention. Stringberg A; Camden R; Qualls K; Naqvi SH Mo Med; 2019; 116(4):303-307. PubMed ID: 31527979 [TBL] [Abstract][Full Text] [Related]
11. Ticagrelor Added to Aspirin in Acute Nonsevere Ischemic Stroke or Transient Ischemic Attack of Atherosclerotic Origin. Amarenco P; Denison H; Evans SR; Himmelmann A; James S; Knutsson M; Ladenvall P; Molina CA; Wang Y; Johnston SC; Stroke; 2020 Dec; 51(12):3504-3513. PubMed ID: 33198608 [TBL] [Abstract][Full Text] [Related]
12. Ticagrelor versus clopidogrel in dual antiplatelet therapy after minor stroke or transient ischemic attack: an updated network meta-analysis. Marinheiro G; Araújo B; Monteiro GA; Leite M; Mutarelli A; Almeida AM; Cavalcante-Neto JF; Rivera A; Pinheiro AC; Telles JPM J Neurol; 2024 Jun; 271(6):3030-3038. PubMed ID: 38580815 [TBL] [Abstract][Full Text] [Related]
13. Bleeding Risk of Dual Antiplatelet Therapy after Minor Stroke or Transient Ischemic Attack. Wang A; Meng X; Tian X; Johnston SC; Li H; Bath PM; Zuo Y; Xie X; Jing J; Lin J; Wang Y; Zhao X; Li Z; Jiang Y; Liu L; Wang F; Li Y; Liu J; Wang Y; Ann Neurol; 2022 Mar; 91(3):380-388. PubMed ID: 34951042 [TBL] [Abstract][Full Text] [Related]
14. Outcomes Associated With Clopidogrel-Aspirin Use in Minor Stroke or Transient Ischemic Attack: A Pooled Analysis of Clopidogrel in High-Risk Patients With Acute Non-Disabling Cerebrovascular Events (CHANCE) and Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trials. Pan Y; Elm JJ; Li H; Easton JD; Wang Y; Farrant M; Meng X; Kim AS; Zhao X; Meurer WJ; Liu L; Dietrich D; Wang Y; Johnston SC JAMA Neurol; 2019 Dec; 76(12):1466-1473. PubMed ID: 31424481 [TBL] [Abstract][Full Text] [Related]
15. Personalised antiplatelet therapy based on pharmacogenomics in acute ischaemic minor stroke and transient ischaemic attack: study protocol for a randomised controlled trial. Zhang XG; Zhu XQ; Xue J; Li ZZ; Jiang HY; Hu L; Yue YH BMJ Open; 2019 May; 9(5):e028595. PubMed ID: 31123001 [TBL] [Abstract][Full Text] [Related]
16. Time Course for Benefit and Risk With Ticagrelor and Aspirin in Individuals With Acute Ischemic Stroke or Transient Ischemic Attack Who Carry CYP2C19 Loss-of-Function Alleles: A Secondary Analysis of the CHANCE-2 Randomized Clinical Trial. Pan Y; Meng X; Jin A; Johnston SC; Li H; Bath PM; Xie X; Jing J; Lin J; Wang Y; Zhao X; Li Z; Jiang Y; Liu L; Yang H; Cheng J; Wang Z; Wang Y JAMA Neurol; 2022 Aug; 79(8):739-745. PubMed ID: 35727586 [TBL] [Abstract][Full Text] [Related]
17. Comparison of Dual Antiplatelet Therapies for Minor, Nondisabling, Acute Ischemic Stroke: A Bayesian Network Meta-Analysis. Lim A; Ma H; Ly J; Singhal S; Pan Y; Wang Y; Johnston SC; Phan TG JAMA Netw Open; 2024 May; 7(5):e2411735. PubMed ID: 38753327 [TBL] [Abstract][Full Text] [Related]
18. Ticagrelor versus Clopidogrel in Wang Y; Meng X; Wang A; Xie X; Pan Y; Johnston SC; Li H; Bath PM; Dong Q; Xu A; Jing J; Lin J; Niu S; Wang Y; Zhao X; Li Z; Jiang Y; Li W; Liu L; Xu J; Chang L; Wang L; Zhuang X; Zhao J; Feng Y; Man H; Li G; Wang B; N Engl J Med; 2021 Dec; 385(27):2520-2530. PubMed ID: 34708996 [TBL] [Abstract][Full Text] [Related]
19. Effect of ticagrelor versus clopidogrel on platelet reactivity measured by thrombelastography in patients with minor stroke or TIA. Yang Y; Chen W; Pan Y; Yan H; Meng X; Liu L; Wang Y; Wang Y Aging (Albany NY); 2020 Oct; 12(20):20085-20094. PubMed ID: 33065552 [TBL] [Abstract][Full Text] [Related]
20. Ticagrelor plus aspirin versus clopidogrel plus aspirin for platelet reactivity in patients with minor stroke or transient ischaemic attack: open label, blinded endpoint, randomised controlled phase II trial. Wang Y; Chen W; Lin Y; Meng X; Chen G; Wang Z; Wu J; Wang D; Li J; Cao Y; Xu Y; Zhang G; Li X; Pan Y; Li H; Zhao X; Liu L; Lin J; Dong K; Jing J; Johnston SC; Wang D; Wang Y; BMJ; 2019 Jun; 365():l2211. PubMed ID: 31171523 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]